Etaphylline

Etaphylline: Symptomatic Relief for Chronic Respiratory Issues

Etaphylline is a medication specifically designed to help manage symptoms of dyspnea (shortness of breath) in patients with chronic broncho-pneumopathies and pulmonary emphysema, without causing respiratory decompensation. It is a theophylline derivative that acts as a direct bronchodilator, relaxing smooth muscles and relieving bronchospasm. This makes it an effective adjunctive therapy for conditions like asthma, bronchitis, and biliary colic, as well as cardiac insufficiency.

Each coated tablet contains 0.250 grams of acefylline piperazine. The recommended dosage is 2 to 6 tablets daily, taken in several doses at regular intervals throughout the day. This ensures consistent relief from respiratory symptoms, allowing patients to breathe more easily and maintain their quality of life.

Etaphylline is available in sugar-coated tablets, packaged in boxes of 24, 48, or 96 tablets, making it convenient for long-term management of chronic respiratory conditions. Its minimal gastric irritation and lower toxicity compared to other theophylline derivatives make it a preferred choice for many patients. By providing sustained relief from bronchospasm and improving respiratory function, Etaphylline helps patients cope with the challenges of chronic respiratory diseases.